BAFS - Overview: Bile Acids, Fractionated and Total, Serum

Test Catalog

Test ID: BAFS    
Bile Acids, Fractionated and Total, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Measurement of tauro- and glycol-conjugated and unconjugated bile acid constituents in serum

 

Monitoring patients receiving bile acid therapy, such as cholic acid, deoxycholic acid, or ursodeoxycholic acid

 

Aiding in the evaluation of liver function; evaluation of liver function changes before the formation of more advanced clinical signs of illness such as icterus

 

Determining hepatic dysfunction as a result of chemical and environmental injury

 

Indication of hepatic histological improvement in chronic hepatitis C patients responding to interferon treatment

 

Indication of intrahepatic cholestasis of pregnancy

Highlights

Bile acids are elevated in individuals with liver dysfunction.

 

Fractionated bile acids, including tauro- and glycol-conjugates of cholic acid, chenodeoxycholic acid, deoxycholic acid, and ursodeoxycholic acid are individually summed and reported.

Method Name A short description of the method used to perform the test

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Bile Acids, Fractionated and Tot, S

Aliases Lists additional common names for a test, as an aid in searching

Bile Acid